Baxter International | BAX - Creditori Commerciali

Prezzo Delle Azioni
17.62
Cambio Giornaliero
0.54 3.16%
Mensile
-19.43%
Annuale
-48.94%
Q1 Previsione
16.87




Creditori Commerciali Cambiamento Data
Abbott USD 4.12B 183M 2025-09
AngioDynamics USD 30.26M 4.48M 2025-02
Artivion USD 16.04M 454K 2025-12
AtriCure USD 78.4M 3.56M 2025-12
Avanos Medical USD 55.5M 1.3M 2025-12
Baxter International USD 999M 46M 2025-12
Becton, Dickinson and Co. USD 6.14B 4.16B 2025-12
Boston Scientific USD 1.14B 142M 2025-12
Cooper Companies USD 225.8M 74.6M 2025-12
Dexcom USD 1.83B 1.38B 2025-12
Edwards Lifesciences USD 165M 94.2M 2025-09
Fresenius EUR 1.08B 65M 2025-09
Globus Medical USD 98.85M 11.62M 2025-12
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
ICU Medical USD 154.37M 17.38M 2025-12
Inogen USD 21.22M 684K 2025-09
Insulet USD 75M 26.8M 2025-12
Integra LifeSciences USD 95.73M 3.42M 2025-12
Intuitive Surgical USD 1.92B 179.7M 2025-12
J&J USD 11.99B 2.37B 2025-12
Laboratory Of America USD 840.8M 172.3M 2025-12
Masimo USD 103M 14.9M 2025-12
Medtronic USD 2.58B 26M 2025-09
Merit Medical Systems USD 60.55M 4.19M 2025-12
Quest Diagnostics USD 1.6B 143M 2025-12
Smith & Nephew USD 1.19B 73M 2025-12
Stryker USD 1.5B 56M 2025-09
Tandem Diabetes Care USD 47.07M 414K 2025-12
Teleflex USD 130.2M 35.71M 2025-12
Terumo JPY 97.49B 4.46B 2025-12
Zimmer Biomet Holdings USD 303M 12.3M 2025-12